Back to search

University of Thessaly (UTH)

Ο ρόλος της τροποποιημένης από την ισχαιμία αλβουμίνης σε ασθενείς με COVID-19

Abstract

dc:description

COVID-19, the disease caused by SARS-CoV-2, represented one of the most severe public health crisis of the modern era. With millions of infections and deaths worldwide, the pandemic has highlighted the need for a deeper understanding of the disease’s pathophysiology and the development of new methods for diagnosis, prognosis and treatment. One of the critical factors studied in managing the disease is biomarkers, which can provide information about inflammation, thrombosis and disease severity. The present study focuses on the role of ischemia-modified albumin (IMA) as a prognostic tool in the management of patients with COVID-19. The aim is to investigate the significance of IMA in patients with COVID-19 by examining its association with markers of inflammation, thrombosis and clinical outcomes. Furthermore, we assess whether it can serve as a biomarker for disease severity, ICU admission and mortality, contributing to targeted therapy. The study included 199 patients, 135 in the COVID-19 group and 64 in the control group. In the COVID-19 group, the majority of patients were male (62.2%), while the most common comorbidity was arterial hypertension (43.7%). Our findings indicate that IMA levels are significantly elevated in COVID-19 patients compared to the control group [24.38 (11.94) ng/ml vs 14.69 (3.52) ng/ml, p < 0.01]. Additionally, admission IMA levels were associated with in-hospital mortality (p = 0.01) [AUC (95% Cl) 68% (54.3-81.3) (sensitivity: 100%, specificity: 37%) with cut-off value 20.82 ng/ml] but did not show a correlation with ICU admission or the development of acute respiratory distress syndrome. In conclusion, IMA is a highly promising biomarker for the severity and prognosis of COVID-19, contributing to a better understanding of the disease’s pathophysiology.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Pagonis, Athanasios
  • Παγώνης, Αθανάσιος

Subjects

dc:subject × 9

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61522

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Pagonis, Athanasios; Παγώνης, Αθανάσιος. Ο ρόλος της τροποποιημένης από την ισχαιμία αλβουμίνης σε ασθενείς με COVID-19. University of Thessaly (UTH), 2025. http://hdl.handle.net/10442/hedi/61522